Biofil Chemicals & Pharmaceuticals (NSE:BIOFILCHEM) EPS (Basic): ₹1.71 (TTM As of Mar. 2026)


NSE:BIOFILCHEM Biofil Chemicals & Pharmaceuticals Ltd NSE:BIOFILCHEM
71 GF Score
Price ₹36.07
GF Value ₹41.69
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Biofil Chemicals & Pharmaceuticals EPS (Basic)?

Biofil Chemicals & Pharmaceuticals NSE:BIOFILCHEM +0.75% 71 EPS (Basic) is ₹1.71 as of Mar. 2026. GuruFocus rates NSE:BIOFILCHEM with a GF Score™ of 71/100 and a GF Value™ of ₹41.69 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Biofil Chemicals & Pharmaceuticals's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ₹0.13. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹1.71.

Biofil Chemicals & Pharmaceuticals's EPS (Diluted) for the three months ended in Mar. 2026 was ₹0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹1.58.

Biofil Chemicals & Pharmaceuticals's EPS without NRI for the three months ended in Mar. 2026 was ₹0.13. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 1.71.

During the past 12 months, Biofil Chemicals & Pharmaceuticals's average EPS without NRIGrowth Rate was 402.90% per year. During the past 3 years, the average EPS without NRI Growth Rate was 71.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 12.90% per year. During the past 10 years, the average EPS without NRI Growth Rate was 2.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Biofil Chemicals & Pharmaceuticals's highest 3-Year average EPS without NRI Growth Rate was 71.30% per year. The lowest was -22.80% per year. And the median was -7.60% per year.

Biofil Chemicals & Pharmaceuticals  (NSE:BIOFILCHEM) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Biofil Chemicals & Pharmaceuticals EPS (Basic) Related Terms

Biofil Chemicals & Pharmaceuticals EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Biofil Chemicals & Pharmaceuticals's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biofil Chemicals & Pharmaceuticals EPS (Basic) Chart

Biofil Chemicals & Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.44 0.34 0.44 0.34 1.71

Biofil Chemicals & Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 1.48 0.05 0.05 0.13
NSE:BIOFILCHEM
71GF Score
Biofil Chemicals & Pharmaceuticals Ltd NSE:BIOFILCHEM
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biofil Chemicals & Pharmaceuticals EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Biofil Chemicals & Pharmaceuticals's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(27.86-0)/16.292
=1.71

Biofil Chemicals & Pharmaceuticals's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(2.122-0)/16.323
=0.13

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹1.71 mean?
Biofil Chemicals & Pharmaceuticals (NSE:BIOFILCHEM) has a EPS (Basic) of ₹1.71 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Biofil Chemicals & Pharmaceuticals and its competitors.
Is Biofil Chemicals & Pharmaceuticals' EPS (Basic) too high?
Biofil Chemicals & Pharmaceuticals' current EPS (Basic) is ₹1.71. Overall, Biofil Chemicals & Pharmaceuticals has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Biofil Chemicals & Pharmaceuticals' EPS (Basic) compare to ZTS?
Biofil Chemicals & Pharmaceuticals' EPS (Basic) of ₹1.71 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Biofil Chemicals & Pharmaceuticals and its competitors. Biofil Chemicals & Pharmaceuticals's current EPS (Basic) is ₹1.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biofil Chemicals & Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Biofil Chemicals & Pharmaceuticals (NSE:BIOFILCHEM) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹41.69, compared to a current price of ₹36.07 — trading 13.5% below its estimated fair value. The current EPS (Basic) is ₹1.71. Biofil Chemicals & Pharmaceuticals' overall GF Score™ is 71/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Biofil Chemicals & Pharmaceuticals (NSE:BIOFILCHEM), the current EPS (Basic) is ₹1.71 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biofil Chemicals & Pharmaceuticals (NSE:BIOFILCHEM) Overvalued in 2026?

Based on GuruFocus' analysis, Biofil Chemicals & Pharmaceuticals stock appears to be undervalued. The current stock price of ₹36.07 is trading 13.5% below its estimated GF Value™ of ₹41.69. GuruFocus considers Biofil Chemicals & Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for NSE:BIOFILCHEM:

  • EPS (Basic): ₹1.71
  • GF Value™: ₹41.69 vs. price of ₹36.07 (13.5% below fair value)
  • GF Score™: 71/100 with 7 warning signs

No single metric tells the full story. See the NSE:BIOFILCHEM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biofil Chemicals & Pharmaceuticals Business Description

Other Exchanges 524396:India
Address 11/12, Sector E Sanwer Road, Industrial Area, Indore, MP, IND, 452015
Biofil Chemicals & Pharmaceuticals Ltd is an Indian pharmaceutical company. It deals in the manufacturing and trading of pharmaceuticals. Further, the company also deals in providing job work facilities with respect to the manufacturing of pharmaceutical drugs. Its product portfolio comprises basic drugs and pharmaceuticals such as sodium citrate, sodium chloride, ferrous sulphate, micro crystalline cellulose, dicyclomine hydrochloride, and others. The company's operating segments are: Pharma, which derives maximum revenue, and Chemicals. Geographically, it caters to both domestic and international markets.
71GF Score

Get the complete analysis for NSE:BIOFILCHEM

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹36.07
Price
₹41.69
GF Value